| Enzyme responsive drug delivery systems in cancer treatment M Shahriari, M Zahiri, K Abnous, SM Taghdisi, M Ramezani, M Alibolandi Journal of Controlled Release 308, 172-189, 2019 | 274 | 2019 |
| Synthesis of hyaluronic acid-based polymersomes for doxorubicin delivery to metastatic breast cancer M Shahriari, SM Taghdisi, K Abnous, M Ramezani, M Alibolandi International Journal of Pharmaceutics 572, 118835, 2019 | 56 | 2019 |
| Self-targeted polymersomal co-formulation of doxorubicin, camptothecin and FOXM1 aptamer for efficient treatment of non-small cell lung cancer M Shahriari, SM Taghdisi, K Abnous, M Ramezani, M Alibolandi Journal of Controlled Release 335, 369-388, 2021 | 37 | 2021 |
| “Smart” self-assembled structures: toward intelligent dual responsive drug delivery systems M Shahriari, VP Torchilin, SM Taghdisi, K Abnous, M Ramezani, ... Biomaterials Science 8 (21), 5787-5803, 2020 | 28 | 2020 |
| Anticancer potential of curcumin-cyclodextrin complexes and their pharmacokinetic properties M Shahriari, P Kesharwani, TP Johnston, A Sahebkar International Journal of Pharmaceutics 631, 122474, 2023 | 20 | 2023 |
| Smart polymersomes as intelligent nanomedicines in cancer treatment M Alibolandi, M Shahriari, M Ramezani Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics …, 2019 | 17 | 2019 |
| Design and synthesis of targeted star-shaped micelle for guided delivery of camptothecin: In vitro and in vivo evaluation M Sahranavard, M Shahriari, K Abnous, F Hadizadeh, SM Taghdisi, ... Materials Science and Engineering: C 131, 112529, 2021 | 13 | 2021 |
| Aptamer-based theranostic approaches for treatment of cancer M Shahriari, P Kesharwani, A Sahebkar Aptamers engineered nanocarriers for cancer therapy, 433-454, 2023 | 4 | 2023 |
| Development of PNC-27 targeted codelivery system for survivin-shRNA and SN38 against colon adenocarcinoma in vitro and in vivo S Taghavi, M Shahriari, K Abnous, SM Taghdisi, M Alibolandi, ... Journal of Drug Delivery Science and Technology 69, 103180, 2022 | 1 | 2022 |
| Principal concept in PEGylated dendrimer-based cancer therapeutics M Alibolandi, M Shahriari, M Ramezani Dendrimer-Based Nanotherapeutics, 183-202, 2021 | | 2021 |
Mona AlibolandiAssociate Prof. of Medical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences在 mums.ac.ir 的电子邮件经过验证
